With this new Senior Research Award (K05), the principal investigator will continue to pursue her clinical research career goal of improving the treatment of alcohol dependence by 1) integrating three domains of clinical research; psychotherapeutic interventions, pharmacotherapy development, human bio-behavioral laboratory studies, 2) training new clinical researchers, and 3) educating the treatment community about new treatments. She will also conduct research on alcohol and tobacco interactions. In order to sustain her performance as a leader in clinical research and psychopharmacology, she will continue extensive collaborations in interdisciplinary research. Continued scientific growth will benefit as well from activities related to mentoring and participation in research review and advisory group participation. The research plan is focused on the COMBINE Study. Plans for future research include using human laboratory paradigms to screen new medications for alcohol dependence and to take these into clinical trials. The COMBINE study is a NIAAA sponsored multi-site clinical trial designed to answer questions about the benefits of combining behavioral and pharmacological interventions. Two medications, naltrexone and acamprosate, have shown promise in reducing relapse to heavy drinking and improving abstinence in a number of U.S. and European clinical trials. The two behavioral treatments, Medical Management (MM) and Combined Behavioral Intervention (CBI), have potential to be valuable adjuncts to pharmacotherapy. MM appears to be cost-effective and suitable for delivery in primary care or managed care settings by non-specialists. The primary hypothesis is that combining the two medications (naltrexone and acamprosate) with a moderate intensity behavioral treatment (CBI) will yield better outcomes than less intensive approaches (e.g., placebo and MM; acamprosate or naltrexone and MM) for alcohol dependent patients. A total of 1375 subjects from 11 clinical sites comprise the targeted sample for this 16 week trial with long-term follow-up. Individuals meeting study criteria are randomly assigned to one of nine pharmacological (naltrexone and acamprosate) and behavioral treatment (MM and CBI) combinations to form a complete 2X2X2 factorial design. A ninth cell is included to test the efficacy of CBI without """"""""pills."""""""" Ultimately, the results of this study will have important implications for the treatment of alcoholism in the United States.

National Institute of Health (NIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Research Scientist Award (K05)
Project #
Application #
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Fertig, Joanne
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Leeman, Robert F; Nogueira, Christine; Wiers, Reinout W et al. (2018) A Test of Multisession Automatic Action Tendency Retraining to Reduce Alcohol Consumption Among Young Adults in the Context of a Human Laboratory Paradigm. Alcohol Clin Exp Res 42:803-814
Geha, Paul; Cecchi, Guillermo; Todd Constable, R et al. (2017) Reorganization of brain connectivity in obesity. Hum Brain Mapp 38:1403-1420
Zweben, A; Piepmeier, M E; Fucito, L et al. (2017) The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial. J Subst Abuse Treat 77:72-78
Hillmer, A T; Sandiego, C M; Hannestad, J et al. (2017) In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence. Mol Psychiatry 22:1759-1766
Sartor, Carolyn E; O'Malley, Stephanie S (2016) Brief Report: A web-based pilot study of childhood sexual abuse, recent stressful events, and alcohol use in women. Am J Addict 25:184-7
Tsai, Wan-Min; Zhang, Heping; Buta, Eugenia et al. (2016) A modified classification tree method for personalized medicine decisions. Stat Interface 9:239-253
Esterlis, Irina; Hillmer, Ansel T; Bois, Frederic et al. (2016) CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation. Nicotine Tob Res 18:1845-52
Hillmer, Ansel T; Kloczynski, Tracy; Sandiego, Christine M et al. (2016) Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence. Alcohol Clin Exp Res 40:698-705
Leeman, Robert F; DeMartini, Kelly S; Gueorguieva, Ralitza et al. (2016) Randomized controlled trial of a very brief, multicomponent web-based alcohol intervention for undergraduates with a focus on protective behavioral strategies. J Consult Clin Psychol 84:1008-1015
van Kooten, Maria J; Veldhuizen, Maria G; de Araujo, Ivan E et al. (2016) Fatty acid amide supplementation decreases impulsivity in young adult heavy drinkers. Physiol Behav 155:131-40

Showing the most recent 10 out of 102 publications